Loading...
•
Jun 30, 2024
Mimedx Q2 2024 Earnings Report
Mimedx's financial performance reflected a 7% year-over-year net sales growth and a GAAP net income of $18 million.
Key Takeaways
MiMedx reported a 7% increase in net sales, reaching $87 million for the second quarter of 2024. The company's GAAP net income was $18 million, with an Adjusted EBITDA of $20 million, representing 23% of net sales. The growth was driven by AMNIOEFFECT® and EPIEFFECT® products, despite competitive challenges.
Net sales for Q2 2024 reached $87 million, a 7% increase year-over-year.
GAAP net income for Q2 2024 was $18 million, with a net income margin of 20%.
Adjusted EBITDA for Q2 2024 was $20 million, representing 23% of net sales.
The company launched HELIOGEN™, their first xenograft product.
Revenue by Segment
Forward Guidance
MiMedx expects net sales growth to be in the mid-to-high single-digits as a percentage compared to 2023, due principally to the ongoing uncertainty surrounding Medicare reimbursement policy for skin substitutes in the private office and adjacent care settings. Longer-term, the Company continues to expect to achieve annual net sales growth in the low double-digits as a percentage with an adjusted EBITDA margin above 20%.
Positive Outlook
- Continued expansion of footprint in various surgical settings.
- Commitment to high-quality clinical and scientific research.
- Full market release of first xenograft product, HELIOGEN.
- Expects annual net sales growth in the low double-digits as a percentage.
- Expects adjusted EBITDA margin above 20%.
Challenges Ahead
- Uncertainty surrounding Medicare reimbursement policy for skin substitutes in the private office and adjacent care settings.
- Commercial challenges as a result of certain competitive behavior.
- Several companies continue to engage in schemes to sell artificially high-priced, yet clinically unproven, skin substitutes primarily in the private office, by sharing a substantial portion of the revenue with treating physicians.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...